Skip to main content
European Neighbourhood Policy and Enlargement Negotiations
News article18 September 2020Directorate-General for Neighbourhood and Enlargement Negotiations

Coronavirus Global Response: the Commission's contribution to the COVID-19 Vaccine Global Access Facility (COVAX)

Today, the European Commission confirmed its participation in the COVAX Facility for equitable access to affordable COVID-19 vaccines, following its expression of interest on 31 August and its announcement of a contribution of €400 million.

Coronavirus global response

Today, the European Commission confirmed its participation in the COVAX Facility for equitable access to affordable COVID-19 vaccines, following its expression of interest on 31 August and its announcement of a contribution of €400 million. In a joint effort between the European Commission and the 27 EU Member States, Team Europe will contribute with an initial €230 million in cash through a loan from the European Investment Bank, backed by the same amount in guarantees provided by the EU budget. A contribution of €230 million is equivalent to reserves or options to buy 88 million doses and the EU would transfer these to eligible Advanced Market Commitment (AMC) countries. This contribution is complemented with €170 million in financial guarantees from the EU budget. Ursula von der Leyen, President of the European Commission, said: “It is not enough to find a vaccine. We must make sure that citizens around the world have access to it. Our strong commitment to the COVAX Facility is an another sign to all citizens who need the vaccine that we stand with them, wherever they are. No one is safe until everyone is safe”. Stella Kyriakides, Commissioner for Health and Food Safety, said: “Being part of the COVAX Facility means ensuring its success and providing access to vaccines for low and middle income countries. It means ensuring access not only for those who can afford it – but to all citizens globally. And it means showing solidarity and global leadership. It is only together that we will be able to overcome COVID-19”. Jutta Urpilainen, Commissioner for International partnerships, said: “With this contribution to COVAX, the EU is demonstrating that we are serious about leaving no one behind. The future vaccines for COVID-19 should not be a luxury for the rich but a global public good. We need to guarantee that those that most need it have access to it irrespective of where they live”.The COVAX Facility, co-led by Gavi (the Vaccine Alliance), the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO, aims to accelerate the development and manufacturing of COVID-19 vaccines and to guarantee fair and equitable access for every country in the world. A full press release is available online.

Details